{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:16:40Z","timestamp":1786947400411,"version":"build-2736575974"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ajem.2022.05.005","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:28:39Z","timestamp":1652142519000},"page":"350.e5-350.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids"],"prefix":"10.1016","volume":"58","author":[{"given":"Sterling C.","family":"Torian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Negrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2022.05.005_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"13","key":"10.1016\/j.ajem.2022.05.005_bb0010","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa1807652","article-title":"An outbreak of synthetic cannabinoid\u2013associated coagulopathy in Illinois","volume":"379","author":"Kelkar","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ajem.2022.05.005_bb0015","first-page":"237","article-title":"Management of rodenticide poisoning associated with synthetic cannabinoids","volume":"36","author":"Godwin","year":"2019","journal-title":"Fed Pract"},{"issue":"36","key":"10.1016\/j.ajem.2022.05.005_bb0020","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017015","article-title":"Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides: observational case series and management recommendations","volume":"98","author":"Bahouth","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.ajem.2022.05.005_bb0025","doi-asserted-by":"crossref","DOI":"10.33176\/AACB-19-00029","article-title":"Superwarfarin (Long-acting anticoagulant rodenticides) poisoning: from pathophysiology to laboratory-guided clinical management","volume":"40","author":"Chong","year":"2019","journal-title":"Clin Biochem Rev"},{"issue":"18","key":"10.1016\/j.ajem.2022.05.005_bb0030","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1021\/jm3008213","article-title":"7-alkyl-3-benzylcoumarins: a versatile scaffold for the development of potent and selective cannabinoid receptor agonists and antagonists","volume":"55","author":"Rempel","year":"2012","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.ajem.2022.05.005_bb0035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tmrv.2015.06.002","article-title":"Long-acting anticoagulant rodenticide (superwarfarin) poisoning: a review of its historical development, epidemiology, and clinical management","volume":"29","author":"King","year":"2015","journal-title":"Transfus Med Rev"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722003047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722003047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:05:14Z","timestamp":1760025914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675722003047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":7,"alternative-id":["S0735675722003047"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2022.05.005","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2022.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}